• Built and led the bioinformatics team dedicated to the development, improvement, and validation of clinical cancer assays.• Managed a team of five, providing mentorship and guidance, facilitating professional development, and ensuring alignment with project objectives.• Successfully managed multiple projects using hybrid project management methodologies, meeting tight deadlines, and in compliance with accreditation standards.• Coordinated multidisciplinary collaboration among bioinformatics, laboratory, and computational biology teams, ensuring timely delivery of clinical assays and enhancing project alignment with organizational goals.• Managed bioinformatics support for internal and external stakeholders, overseeing review of reports and communication with stakeholders.

• Validated and optimised the performance of clinical cancer assays for College of American Pathologists (CAP) and Diagnostic Accreditation Program (DAP) accreditation, and distribution to global partner companies.• Designed, tested, and implemented improvements to assays and bioinformatics pipelines, including primer design, optimisation of laboratory protocols, SNV and indel calling methods, and defining appropriate quality control metrics.• Performed quality-assurance analysis on clinical assay results.• Aggregated data from thousands of samples to generate comprehensive reports detailing trends in study cohorts and monitoring assay performance over time.• Involved with transfer of cancer assay and bioinformatics pipeline to global partner companies.

• Lead researcher on Chronic Complex Disease Project, aiming to identify infectious causes for chronic diseases of unknown aetiology, including Chronic Fatigue Syndrome• Designed, evaluated and implemented a bioinformatic metagenomics pipeline to identify infectious agents from Illumina sequence data generated from participants’ plasma• Carried out statistical analysis of detailed epidemiological data, including database construction for storage of participant details• Bioinformatician on multiple next-generation sequencing projects based at the British Columbia Centre for Disease Control, including evolutionary analysis of MRSA in rats, within host evolution of Burkholderia in Cystic Fibrosis patients, metagenomic analysis of swine samples from a disease outbreak of unknown aetiology, exploratory metagenomic analysis of rats from Vancouver Downtown Eastside and genomic analysis of an outbreak of Streptococcus pneumoniae

• Completed case control study for determination of factors leading to community-acquired MRSA bacteraemia• Used MLST and PCR to investigate the relationships between molecular genetic markers and patient history, demographics and antibiotic resistance